Literature DB >> 16534773

Cognitive decline and survival in Alzheimer's disease.

Robert S Wilson1, Yan Li, Neelum T Aggarwal, Judy J McCann, David W Gilley, Julia L Bienias, Lisa L Barnes, Denis A Evans.   

Abstract

OBJECTIVE: To test the association of rate of cognitive decline, an indicator of the severity of the underlying disease process, with risk of death in Alzheimer's disease (AD).
METHODS: A total of 472 persons with clinically diagnosed AD were recruited from a memory disorders clinic and day care centers in the Chicago area. They completed a uniform clinical evaluation at baseline and a battery of nine cognitive tests at six-month intervals for a mean of about three years. A previously established measure of global cognition was derived from the nine tests.
RESULTS: During follow-up, 168 persons (36%) died. In a proportional hazards model that controlled for age, sex, race, education, and baseline level of cognition, individual rate of global cognitive decline, estimated with least squares regression, was linearly related to mortality risk. Thus, a person declining minimally (increase of 0.04 unit per year, 90th percentile) was 2.7 times less likely to die during the study period than a person declining rapidly (decrease of 0.76 unit per year, 10th percentile). Controlling for baseline disability did not substantially affect results. The association of cognitive decline with mortality was substantially stronger for white persons compared to African Americans and in those with less compared to more education.
CONCLUSION: The results indicate that the rate at which cognition declines in AD is robustly related to survival. Copyright (c) 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2006        PMID: 16534773     DOI: 10.1002/gps.1472

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  11 in total

1.  Occupational attainment influences survival in autopsy-confirmed frontotemporal degeneration.

Authors:  Lauren Massimo; Jarcy Zee; Sharon X Xie; Corey T McMillan; Katya Rascovsky; David J Irwin; Ann Kolanowski; Murray Grossman
Journal:  Neurology       Date:  2015-04-22       Impact factor: 9.910

2.  FLZ, synthetic squamosamide cyclic derivative, attenuates memory deficit and pathological changes in mice with experimentally induced aging.

Authors:  Fang Fang; Qing-li Wang; Geng-tao Liu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-03-24       Impact factor: 3.000

3.  Factors affecting survival of patients with neurodegenerative disease.

Authors:  Kyle Steenland; Jessica MacNeil; Ryan Seals; Allan Levey
Journal:  Neuroepidemiology       Date:  2010-04-08       Impact factor: 3.282

4.  The effect of maintaining cognition on risk of disability and death.

Authors:  Kristine Yaffe; Karla Lindquist; Eric Vittinghoff; Deborah Barnes; Eleanor M Simonsick; Anne Newman; Suzanne Satterfield; Caterina Rosano; Susan M Rubin; Hilsa N Ayonayon; Tamara Harris
Journal:  J Am Geriatr Soc       Date:  2010-04-06       Impact factor: 5.562

5.  Cognitive decline in incident Alzheimer disease in a community population.

Authors:  R S Wilson; N T Aggarwal; L L Barnes; C F Mendes de Leon; L E Hebert; D A Evans
Journal:  Neurology       Date:  2010-03-23       Impact factor: 9.910

6.  Personality traits, cognitive states, and mortality in older adulthood.

Authors:  Tomiko Yoneda; Eileen Graham; Tristen Lozinski; David A Bennett; Daniel Mroczek; Andrea M Piccinin; Scott M Hofer; Graciela Muniz-Terrera
Journal:  J Pers Soc Psychol       Date:  2022-04-11

7.  Biracial population study of mortality in mild cognitive impairment and Alzheimer disease.

Authors:  Robert S Wilson; Neelum T Aggarwal; Lisa L Barnes; Julia L Bienias; Carlos F Mendes de Leon; Denis A Evans
Journal:  Arch Neurol       Date:  2009-06

8.  Volumetric changes within hippocampal subfields in Alzheimer's disease continuum.

Authors:  Emre Hari; Elif Kurt; Ali Bayram; Gozde Kizilates-Evin; Burak Acar; Tamer Demiralp; Hakan Gurvit
Journal:  Neurol Sci       Date:  2022-01-18       Impact factor: 3.307

9.  Longitudinal associations between dietary quality and Alzheimer's disease genetic risk on cognitive performance among African American adults.

Authors:  Sharmin Hossain; Michele K Evans; Alan B Zonderman; May A Beydoun; Jordan Weiss; Marie F Kuczmarski
Journal:  Br J Nutr       Date:  2020-04-06       Impact factor: 3.718

10.  Disease-related determinants are associated with mortality in dementia due to Alzheimer's disease.

Authors:  Hanneke F M Rhodius-Meester; Hilkka Liedes; Ted Koene; Afina W Lemstra; Charlotte E Teunissen; Frederik Barkhof; Philip Scheltens; Mark van Gils; Jyrki Lötjönen; Wiesje M van der Flier
Journal:  Alzheimers Res Ther       Date:  2018-02-20       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.